Abstract | INTRODUCTION/OBJECTIVES: METHODS: A randomized, double-blind, placebo-controlled study was conducted. The final sample consisted of 21 male patients with mild to severe OSA and AHI >10 divided into two groups, a donepezil-treated group (n=11) and a placebo-treated group (n=10). The dosage was one tablet/day (5 mg) for the first two weeks and two tablets/day (10 mg) for the last two weeks. Polysomnography and sleepiness evaluations were performed at baseline and after one month of treatment. Groups were compared using two-way ANOVA for repeated measures with treatment-group and treatment-time as the main factors and time-treatment as an interaction effect. RESULTS: Considering the effect of the interaction with time-treatment, there was a significant improvement in the obstructive apnea/hypopnea index, desaturation index, percentage of time with O(2) saturation ≤3% lower than baseline, lowest oxygen saturation, and the Epworth Sleepiness Scale (ESS) scores with donepezil treatment (p<0.05). Sleep efficiency significantly decreased (p<0.01). CONCLUSIONS:
|
Authors | Lucia Sukys-Claudino, Walter Moraes, Christian Guilleminault, Sergio Tufik, Dalva Poyares |
Journal | Sleep medicine
(Sleep Med)
Vol. 13
Issue 3
Pg. 290-6
(Mar 2012)
ISSN: 1878-5506 [Electronic] Netherlands |
PMID | 22281004
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2011 Elsevier B.V. All rights reserved. |
Chemical References |
- Cholinesterase Inhibitors
- Indans
- Piperidines
- Placebos
- Donepezil
- Oxygen
|
Topics |
- Adult
- Aged
- Cholinesterase Inhibitors
(administration & dosage, adverse effects)
- Donepezil
- Double-Blind Method
- Humans
- Indans
(administration & dosage, adverse effects)
- Male
- Middle Aged
- Oxygen
(blood)
- Piperidines
(administration & dosage, adverse effects)
- Placebos
- Polysomnography
- Sleep Apnea, Obstructive
(diagnosis, drug therapy)
- Sleep Stages
(drug effects)
- Treatment Outcome
|